Assessment of physicochemical alterations in 3D-printed biodegradable implants under biomimetic conditions for cranial defect repair
Once implanted, biodegradable devices gradually deteriorate, potentially compromising clinical performance. Consequently, evaluating the alterations in physicochemical characteristics after implantation is crucial. Nonetheless, there is currently no established methodology for precisely assessing these alterations. This study sought to develop accurately simulated cranial defect physiological conditions (SCDPC) and examine the physicochemical modifications in biodegradable cranioplasty plates (BCP) to anticipate their performance changes following implantation in humans. We analyzed the physicochemical property alterations of BCP following 24 weeks of exposure to SCDPC. Following 24 weeks under SCDPC, the BCP showed a notable reduction in mass (- 0.79%) and tensile strength (- 69.30%). A decrease in molecular weight was noted after 12 weeks of implantation in rabbits (- 9.67%) and following 12 weeks of exposure to SCDPC (- 4.73%). The physicochemical alterations identified under simulated in vitro cranial defect conditions closely mirrored those found in the in vivo setting. In summary, assessing BCP under SCDPC offers an innovative and dependable approach for precisely forecasting performance shifts after implantation. This strategy could provide meaningful guidance for the advancement of BCP and various other biodegradable medical devices.
Authors
- Yeji Cheon
- J. Chung (ORCID: https://orcid.org/0000-0001-9563-5487)
- Jihee Jeong
- J. H. Kim
- E S Lee
- Joonho Eom
- Yeonguk Seong
- Sangbae Park
Institutions
- Seoul National University (KR)
- National Institute of Food and Drug Safety Evaluation (KR)
- National University College (PR)
Publication Details
- Journal
- Biomedical Microdevices
- Published
- 2026-01-07
- DOI
- https://doi.org/10.1007/s10544-025-00788-5
- Primary Topic
- Traumatic Brain Injury and Neurovascular Disturbances
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Ministry of Food and Drug Safety